Market Value1,666,838,000
Total Holdings79
File Date2021-08-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RARE / Ultragenyx Pharmaceutical Inc.
ANNX / Annexon, Inc.
BAX / Baxter International Inc.
YMAB / Y-mAbs Therapeutics, Inc.
AVTR / Avantor, Inc.
ALDX / Aldeyra Therapeutics, Inc.
XENT / Intersect ENT Inc
INSM / Insmed Incorporated
CDXS / Codexis, Inc.
JAZZ / Jazz Pharmaceuticals plc
KRYS / Krystal Biotech, Inc.
ELV / Elevance Health, Inc.
BTAI / BioXcel Therapeutics, Inc.
EBS / Emergent BioSolutions Inc.
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
QTRX / Quanterix Corporation
RLAY / Relay Therapeutics, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
HRC / Hill-Rom Holdings Inc
STIM / Neuronetics, Inc.
ZYME / Zymeworks Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
PRTA / Prothena Corporation plc
MEIP / MEI Pharma, Inc.
APTO / Aptose Biosciences Inc.
MCK / McKesson Corporation
GKOS / Glaukos Corporation
TCRR / Tcr2 Therapeutics Inc
FATE / Fate Therapeutics, Inc.
NVTA / Invitae Corporation
SLP / Simulations Plus, Inc.
NEO / NeoGenomics, Inc.
CVS / CVS Health Corporation
CDNA / CareDx, Inc.
UHS / Universal Health Services, Inc.
JYNT / The Joint Corp.
ARNA / Arena Pharmaceuticals Inc
SPNE / SeaSpine Holdings Corp
MASS / 908 Devices Inc.
SIEN / Sientra, Inc.
TPTX / Turning Point Therapeutics Inc
ITGR / Integer Holdings Corporation
HCAT / Health Catalyst, Inc.
NUVA / Nuvasive Inc
KRMD / KORU Medical Systems, Inc.
LHCG / LHC Group Inc
PAYX / Paychex, Inc.
QDEL / QuidelOrtho Corporation
BMY / Bristol-Myers Squibb Company
AXNX / Axonics, Inc.
PRGO / Perrigo Company plc
STRO / Sutro Biopharma, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
ICUI / ICU Medical, Inc.
BDX / Becton, Dickinson and Company
ATRC / AtriCure, Inc.
WAT / Waters Corporation
HOLX / Hologic, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
HALO / Halozyme Therapeutics, Inc.
HUM / Humana Inc.
KRTX / Karuna Therapeutics, Inc.
UTHR / United Therapeutics Corporation
OMCL / Omnicell, Inc.
NVST / Envista Holdings Corporation
CI / The Cigna Group
CUTR / Cutera, Inc.
SYNH / Syneos Health Inc - Class A
AKU / Akumin Inc
KIDS / OrthoPediatrics Corp.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
MIRO / Miromatrix Medical Inc
TAK / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc.
AXGN / Axogen, Inc.
ABBV / AbbVie Inc.
PFE / Pfizer Inc.
MODN / Model N, Inc.
SIBN / SI-BONE, Inc.
OPRX / OptimizeRx Corporation
TNDM / Tandem Diabetes Care, Inc.
ATEC / Alphatec Holdings, Inc.